VASCULAR PHARMACEUTICALS

vascular-pharmaceuticals-logo

Vascular Pharmaceuticals is a drug discovery company developing monoclonal antibody treatments for diabetic nephropathy. The company specializes in the fields of biotechnology, medicine, and healthcare. It was founded in 2005 and headquartered in Tarboro, North Carolina.

#SimilarOrganizations #People #Financial #Website #More

VASCULAR PHARMACEUTICALS

Social Links:

Industry:
Biotechnology Diabetes Health Care

Founded:
2005-01-01

Address:
Tarboro, North Carolina, United States

Country:
United States

Website Url:
http://www.vascularpharma.com

Total Employee:
1+

Status:
Active

Contact:
919-345-7933

Email Addresses:
[email protected]

Total Funding:
29 M USD

Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta SPF Google Font API WordPress LetsEncrypt Organization Schema Sitelinks Search Box Nginx Wordpress Plugins


Similar Organizations

metis-therapeutics-logo

METiS Therapeutics

METiS Therapeutics uses integrated drug discovery to develop medicines in a variety of illness areas.

iveric-bio-logo

IVERIC bio

IVERIC bio is a biopharmaceutical company developing novel therapies for age-related macular degeneration.

pliant-therapeutics-logo

Pliant Therapeutics

Pliant Therapeutics focuses on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.

semma-therapeutics-logo

Semma Therapeutics

Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.

Current Employees Featured

david-r-clemmons_image

David R. Clemmons
David R. Clemmons Co-Founder and Chief Scientific Officer @ Vascular Pharmaceuticals
Co-Founder and Chief Scientific Officer
2005-01-01

not_available_image

Elizabeth Stoner
Elizabeth Stoner Chief Development Officer @ Vascular Pharmaceuticals
Chief Development Officer

not_available_image

Richard J. Shea
Richard J. Shea Chief Executive Officer @ Vascular Pharmaceuticals
Chief Executive Officer

bonnie-layman_image

Bonnie Layman
Bonnie Layman Chief Financial Officer @ Vascular Pharmaceuticals
Chief Financial Officer

Founder


david-r-clemmons_image

David R. Clemmons

not_available_image

Laura Maile

Investors List

lumira-ventures_image

Lumira Ventures

Lumira Ventures investment in Series A - Vascular Pharmaceuticals

mpm-capital_image

MPM Capital

MPM Capital investment in Series A - Vascular Pharmaceuticals

intersouth-partners_image

Intersouth Partners

Intersouth Partners investment in Series A - Vascular Pharmaceuticals

cardinal-partners_image

Cardinal Partners

Cardinal Partners investment in Series A - Vascular Pharmaceuticals

longwood-founders-fund_image

Longwood Fund

Longwood Fund investment in Series A - Vascular Pharmaceuticals

intersouth-partners_image

Intersouth Partners

Intersouth Partners investment in Series A - Vascular Pharmaceuticals

mpm-capital_image

MPM Capital

MPM Capital investment in Series A - Vascular Pharmaceuticals

bessemer-venture-partners_image

Bessemer Venture Partners

Bessemer Venture Partners investment in Series A - Vascular Pharmaceuticals

Official Site Inspections

http://www.vascularpharma.com Semrush global rank: 5.5 M Semrush visits lastest month: 1.34 K

  • Host name: 31.220.4.98
  • IP address: 31.220.4.98
  • Location: Amsterdam Netherlands
  • Latitude: 52.3534
  • Longitude: 4.9087
  • Timezone: Europe/Amsterdam
  • Postal: 1091

Loading ...

More informations about "Vascular Pharmaceuticals"

Vascular Pharmaceuticals Diabetes Research Initiatives

Vascular Pharmaceuticals is pioneering a new approach to treat one of the most common complications of diabetes, diabetic nephropathy. This type of kidney disease affects individuals โ€ฆSee details»

Contact Us - Vascular Pharma

Headquarters 79 TW Alexander Drive Research Commons, Building 4401 Suite 200A Research Triangle Park, NC. Mailing address Vascular Pharmaceuticals, Inc.See details»

Patient - vascularpharma.com

Additional information, resources and support for individuals living with diabetic nephropathy is available through the following advocacy and professional organizations: American Diabetes โ€ฆSee details»

Vascular Pharmaceuticals - Crunchbase โ€ฆ

Vascular Pharmaceuticals is a drug discovery company developing monoclonal antibody treatments for diabetic nephropathy. The company specializes in the โ€ฆSee details»

Vascular Pharmaceuticals - VentureRadar

Website: http://www.vascularpharma.com. Vascular Pharmaceuticals, Inc. is a privately held biopharmaceutical company developing VPI-2690B for complications of diabetes such as โ€ฆSee details»

Vascular Pharmaceuticals, Inc.: Drug pipelines, Patents, โ€ฆ

Jul 16, 2023ย ยท Explore Vascular Pharmaceuticals, Inc. with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, 1 news, Disease Domain:Endocrinology and ...See details»

Vascular Pharma - Company Profile - Tracxn

Oct 15, 2024ย ยท Vascular Pharma has 3 institutional investors including Lumira Ventures and Intersouth Partners. Founder? Claim Profile. How many employees does Vascular Pharma โ€ฆSee details»

Vascular Pharmaceuticals - Overview, News & Similar โ€ฆ

View Vascular Pharmaceuticals (www.vascularpharma.com) location in North Carolina, United States , revenue, industry and description. Find related and similar companies as well as โ€ฆSee details»

VASCULAR PHARMACEUTICALS INC. - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for VASCULAR PHARMACEUTICALS INC. of Chapel Hill, NC.See details»

Vascular Pharmaceuticals: Contact Details and Business โ€ฆ

Vascular Pharmaceuticals is a Biotechnology, Pharmaceuticals, and Drug Discovery company located in Chapel Hill, North Carolina with $1.00 Million in revenue and 5 employees. Find top โ€ฆSee details»

Investors and Partners Vascular Pharmaceuticals is โ€ฆ

To learn more about Vascular Pharmaceuticals investment opportunities, please contact Rich Shea, [email protected]See details»

Vascular Pharmaceuticals - PitchBook

Vascular Pharmaceuticals is headquartered in Durham, NC. What is the size of Vascular Pharmaceuticals? Vascular Pharmaceuticals has 7 total employees. What industry is Vascular โ€ฆSee details»

Vascular Pharmaceuticals | Company | RadialReport

Vascular Pharmaceuticals is a drug discovery company developing monoclonal antibody treatments for diabetic nephropathy. The company specializes in the fields of biotechnology, โ€ฆSee details»

Vascular Pharmaceuticals - Craft

Vascular Pharmaceuticals is a biopharmaceutical company specializing in the complications of diabetes, specifically diabetic nephropathy. The company aims to advance its therapeutic โ€ฆSee details»

Vascular Pharmaceuticals Inc. - Company Profiles - BCIQ

Sep 13, 2012ย ยท For the biopharma industry investment, business development and competitive intelligence professionals who require information to support financing, partnering and โ€ฆSee details»

Overview and Employees Official Email & Contacts

The Official Website of the Vascular Pharmaceuticals is http://www.vascularpharma.comSee details»

Our Innovative Approaches to Diabetes Management

Apr 24, 2023ย ยท Vascular Pharmaceuticalsis devoted to delivering groundbreaking solutions to enhance the well-being of individuals living with diabetes. We recognize that the path to โ€ฆSee details»

Vascular Pharmaceuticals Email Format

Vascular Pharmaceuticals uses 1 email formats: 1. first_initial [email protected] (100.0%). Enter a name to find & verify an email >>>See details»

Valsartan vs. Losartan: Key Differences and Similarities

Jan 30, 2024ย ยท Valsartan and losartan are generic blood pressure medications that lower blood pressure and treat heart failure. They both belong to the drug class called angiotensin II โ€ฆSee details»

VPI-2690B - Vascular Pharma

VPI-2690B is a first-in-class subcutaneously (under the skin) administered monoclonal antibody with a unique mechanism of action. Monoclonal antibodies are laboratory-produced molecules โ€ฆSee details»

linkstock.net © 2022. All rights reserved